Why Exact Sciences Stock Sank Today
Shares of Exact Sciences (NASDAQ: EXAS) were sinking 9.2% as of 2:52 p.m. EST on Wednesday. The decline came after the diagnostics company reported disappointing fourth-quarter results following the market close on Tuesday.
Exact Sciences announced Q4 revenue of $466.3 million, up nearly 58% year over year and above the Wall Street consensus estimate of $446 million. However, the company's net loss of $436.8 million, or $2.79 per share, was much worse than the average analyst estimate of a net loss of $0.22 per share.
Image source: Getty Images.
Source Fool.com


